We believe that effective interventions in the field of drug use prevention, treatment and harm reduction are effective only if they can be sustainable over long periods of time. But is sustainability certain?
In the European region, the number of countries that have included prevention, treatment and harm reduction in their national drug intervention policies and strategies has increased (MacGregor & Whiting, 2010 (Hope et al., 2010) . However, funding for these operations should not be taken for granted. Austerity and budgetary cuts in many European countries risk the size, quality and sustainability of these operations (Harm Reduction International, 2012) . In many parts of the world, programmes face widespread challenges in the context of economic and donor uncertainty (e.g. Global Fund in Romania; see ECDC, 2013a ECDC, , 2013b Harm Reduction International, 2012) . Climate changes and their ecologic and economic consequences are likely to exacerbate these challenges (Friedman & Rossi, in press ).
The Greek response to the outbreak showed the importance of engaging all key players in combination approaches. At the national level, the role of public agencies and institutions has been central in detecting and understanding the epidemic, in identifying risk factors 1 and assessing needs for immediate response. 2 Both governmental and non-governmental agencies in the field of specialised treatment and harm reduction, including drug-user groups, offered essential services to HIV-infected people who use drugs and raised awareness among the non-infected. At the international level, European institutions (notably the ECDC and the EMCDDA) and other key experts from all over the world have also contributed substantially with their expertise and policy advocacy. Synergy of key players (persons and institutions) and the combined implementation of evidence-based interventions 3 are prerequisites of best practice (Degenhardt et al., 2010 ). Yet, institutions and best practice depend on ongoing, time-appropriate, political and financial support. And, in countries like Greece, where economic crisis and austerity affect policy decisions, the sustainability of both institutions and programs is at stake.
Integrated and synergistic interventions are very useful and correctly advocated as models of best practice. Yet, intervention "business" remains unfinished if and when successful interventions are discontinued. Obviously, the suggestion here is not to refrain from undertaking integrated interventions with time-limited resources. Instead, we believe that the drug use(r)-related intervention community -individuals as well as systemic stakeholders for health and wellbeing -should not relax on its temporal successes of a well-designed approach. The struggle for political and economic support to anchor effective interventions within financially sustainable and temporally-sensitive systems remains as a critical challenge to relevant stakeholders as well as to local and global communities.
